Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > INSANITY? Doing the same thing, over,
View:
Post by ISAloser247 on Jan 17, 2012 5:04pm

INSANITY? Doing the same thing, over,

.and over and getting the same results! . EVERY TIME there is

some good news ; re;interest from another pharma ,  basically anything that can promote the share price--

a melodrama ensues. HOW MANY TIMES CAN A BOARD CHANGE THE CHAIR??? HOW MANY TIMES CAN

A MAJOR INVESTOR BAIL??? HOW CAN MANGEMENT SCREW UP, SO MUCH, SO BADLY, AND BE ALLOWED TO CONTINUE?     It is a truly disgusting display!   and according to the insightful, meaningful

pundits--I AM TO BLAME FOR THE 'ROBUST' SHARE PRICE!!!!....how many times does Antonanus bid farewell

and then return?...almost as often as the board changes the chair?

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities